Copyright ©ERS Journals Ltd 2006 Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms1 Division of Pulmonary Medicine, Dept of Medicine, Keio University, Tokyo, and 2 Dept of Medicine, Tokyo Electric Power Company Hospital, Tokyo, Japan. CORRESPONDENCE: H. Nakamura, Dept of Medicine, Tokyo Electric Power Company Hospital, 9-2 Shinanomachi, Shinjuku-ku, Tokyo 160-0016, Japan. Fax: 81 343566419. E-mail: hnakamura{at}cpnet.med.keio.ac.jp Keywords: CYP2A6, genetic polymorphism, nicotine, smoking habit
Received: May 12, 2005
The whole gene deletion CYP2A6*4, the defect of the main nicotine oxidase, contributes to limiting lifelong and daily cigarette consumption. However, the effects on smoking habits of CYP2A6*7 and *9, two major functional polymorphisms common in Asian populations, have not been reported.
The present study examined the relationship between polymorphisms *4, *7 and *9 with the smoking habits of 200 Japanese smokers who visited the Keio University Hospital (Tokyo, Japan).
The allele frequencies of *1 (wild type), *4, *7 and *9 were 52, 17, 11 and 20%, respectively. When the three polymorphisms were considered simultaneously, the percentages of homozygous wild type, heterozygote, and homozygous mutants and compound heterozygotes were 26.0, 52.5 and 21.5%, respectively. Homozygous mutants and compound heterozygotes (n = 43) smoked fewer cigarettes daily than heterozygotes (n = 105) and homozygous wild-type individuals (n = 52). Smokers with *7/*7, *9/*9 or *7/*9 had lower daily cigarette consumption than smokers with *1/*1.
In conclusion, polymorphisms *4, *7 and *9 of CYP2A6 were detected in approximately three out of four Japanese smokers, and their daily cigarette consumption was genetically modulated by these functional polymorphisms.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||